Combination pharmaceutical therapies for obesity
ثبت نشده
چکیده
published by Anonymous (not verified) on Tue, 10/08/2013 10:39am Title Combination pharmaceutical therapies for obesity. Publication Type Journal Article Year of Publication 2009 Authors Gadde, KM, Allison, DB Journal Expert Opin Pharmacother Volume 10 Issue 6 Pagination 921-5 Date Published 2009 Apr ISSN 1744-7666
منابع مشابه
Development of a Novel Anti-Obesity Compound with Inhibiting Properties on the Lipid Accumulation in 3T3-L1 Adipocytes
Background: Obesity as a developing global challenge can be characterized by increase in adipocyte number and size arising from adipogenesis. Control of adipogenesis, as a potential strategy, can prevent and manage obesity. So far, the effectiveness of herbal medicine and active ingredients therapies for obesity and metabolic syndrome treatment has been investigated. In this study, a novel comb...
متن کاملObese Diabetic Patients: Impact of Different Management Modalities
Type 2 diabetes is one of the major public health challenges in 21st century. Both environmental changes and genetics are attributed for increased risk of type 2 diabetes. Obesity is the most critical and modifiable risk factor and should be targeted for successful management of diabetes. This review article discusses three main approaches to manage obesity. Three management modalities consider...
متن کاملDramatic functional improvement following bariatric surgery in a patient with pulmonary arterial hypertension and morbid obesity.
Pulmonary arterial hypertension (PAH) and morbid obesity both dramatically impair functional capacity. New therapies have emerged for both conditions, including pharmaceutical agents for the former and bariatric surgery for the latter. The presence of both conditions simultaneously, however, may limit the applicability and effectiveness of these therapies. We report a case of a morbidly obese p...
متن کاملCombination therapy for obesity and metabolic disease.
PURPOSE OF REVIEW There is a growing interest in developing combination therapies for treatment and management of obesity and related metabolic diseases. RECENT FINDINGS Emerging data from recently completed and ongoing randomized clinical trials suggest that certain combination-drug therapies in development have greater efficacy than currently available single-drug therapies in terms of achi...
متن کاملObesity prevalence in the United States--up, down, or sideways?
987 ment, but it is not sufficient. Drug developers must embrace a new paradigm that emphasizes sharing of information and collaboration in testing combinations. In some cases, third parties such as academic consortia or other nonprofit cooperative groups may enable such activities. For example, in 2010, the Biomarkers Consortium — a public–private partnership that includes the National Institu...
متن کامل